Briacell Therapeutics Corp Stock Alpha and Beta Analysis
| BCTX Stock | USD 0.73 0.06 7.59% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Briacell Therapeutics Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Briacell Therapeutics over a specified time horizon. Remember, high Briacell Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Briacell Therapeutics' market risk premium analysis include:
Beta 0.0485 | Alpha 0.37 | Risk 10.99 | Sharpe Ratio 0.0356 | Expected Return 0.39 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Briacell |
Briacell Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Briacell Therapeutics market risk premium is the additional return an investor will receive from holding Briacell Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Briacell Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Briacell Therapeutics' performance over market.| α | 0.37 | β | 0.05 |
Briacell Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Briacell Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Briacell Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Briacell Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Briacell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Briacell Therapeutics shares will generate the highest return on investment. By understating and applying Briacell Therapeutics stock market price indicators, traders can identify Briacell Therapeutics position entry and exit signals to maximize returns.
Briacell Therapeutics Return and Market Media
The median price of Briacell Therapeutics for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 0.77 with a coefficient of variation of 19.61. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 0.77, and mean deviation of 0.12. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 27272 shares by Williams Williams V. of Briacell Therapeutics at 5.31 subject to Rule 16b-3 | 09/06/2024 |
2 | BriaCell Therapeutics prices 8.5M equity offering | 09/11/2024 |
3 | BriaCell Therapeutics Corp. Sees Large Increase in Short Interest | 09/27/2024 |
4 | BriaCell stock gains after trial update | 10/15/2024 |
5 | Disposition of 50000 shares by Embro-pantalony Vaughn C. of Briacell Therapeutics at 8.47 subject to Rule 16b-3 | 11/13/2024 |
About Briacell Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Briacell or other stocks. Alpha measures the amount that position in Briacell Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Net Current Asset Value | 402.0K | 357.4K | Days Payables Outstanding | 18.0K | 18.9K |
Briacell Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Briacell Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Briacell Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Briacell Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Briacell Therapeutics. Please utilize our Beneish M Score to check the likelihood of Briacell Therapeutics' management manipulating its earnings.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 12th of June 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 23rd of October 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 31st of July 2023 Last Financial Announcement | View |
Build Portfolio with Briacell Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Briacell Stock Analysis
When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.